Publications by authors named "Calabrese D"

Article Synopsis
  • A better understanding of chronic lung allograft dysfunction (CLAD) is needed, as it leads to high mortality rates after lung transplants.
  • The study focused on a genetic variation (C3R102G) that enhances complement activation, finding that lung transplant recipients with this variation tend to have poorer outcomes related to CLAD, especially if they develop donor-specific antibodies.
  • In experiments with mice, decreased regulation of the complement system resulted in worse airway damage and increased B cell activity, linking genetic predisposition to complement activation with worse survival outcomes after lung transplantation.
View Article and Find Full Text PDF

An approach is described for high-throughput quality assessment of drug candidate libraries using high-resolution acoustic ejection mass spectrometry (AEMS). Sample introduction from 1536-well plates is demonstrated for this application using 2.5 nL acoustically dispensed sample droplets into an Open Port Interface (OPI) with pneumatically assisted electrospray ionization at a rate of one second per sample.

View Article and Find Full Text PDF
Article Synopsis
  • Imine reductases (IREDs) are valuable for synthesizing chiral amines, with applications in asymmetric imine reduction and reductive aminations of aldehydes and ketones.
  • The study discusses the reductive amination of various carbonyls and dicarbonyls using hydrazines, facilitated by the IRED from Myxococcus stipitatus.
  • A hydrogenase cofactor regeneration system was incorporated to enhance scalability and efficiency of the process, showcasing the significant potential of IREDs in biocatalysis.
View Article and Find Full Text PDF

Despite the increasing demand for efficient and sustainable chemical processes, the development of scalable systems using biocatalysis for fine chemical production remains a significant challenge. We have developed a scalable flow system using immobilized enzymes to facilitate flavin-dependent biocatalysis, targeting as a proof-of-concept asymmetric alkene reduction. The system integrates a flavin-dependent Old Yellow Enzyme (OYE) and a soluble hydrogenase to enable H-driven regeneration of the OYE cofactor FMNH.

View Article and Find Full Text PDF

Lung transplantation aims to improve health-related quality of life (HRQL) and survival. While lung function improvements are associated with these outcomes, the association between physical functioning and these outcomes is less clear. We investigated the association between changes in patient-reported physical functioning and HRQL, chronic lung allograft dysfunction (CLAD), and survival after lung transplantation.

View Article and Find Full Text PDF

Background: Pulmonary ischaemia-reperfusion injury (IRI) is a major contributor to poor lung transplant outcomes. We recently demonstrated a central role of airway-centred natural killer (NK) cells in mediating IRI; however, there are no existing effective therapies for directly targeting NK cells in humans.

Methods: We hypothesised that a depleting anti-CD94 monoclonal antibody (mAb) would provide therapeutic benefit in mouse and human models of IRI based on high levels of (CD94) transcripts in bronchoalveolar lavage samples from lung transplant patients.

View Article and Find Full Text PDF

Background: Chronic lung allograft dysfunction (CLAD) limits survival following lung transplant, but substantial lung damage occurs before diagnosis by traditional methods. We hypothesized that small airway gene expression patterns could identify CLAD risk before spirometric diagnosis and predict subsequent graft failure.

Methods: Candidate genes from 4 rejection-associated transcript sets were assessed for associations with CLAD or graft failure in a derivation cohort of 156 small airway brushes from 45 CLAD cases and 37 time-matched controls with >1-year stable lung function.

View Article and Find Full Text PDF

Up to 90% of the global population has been infected with cytomegalovirus (CMV), a herpesvirus that remains latent for the lifetime of the host and drives immune dysregulation. CMV is a critical risk factor for poor outcomes after solid organ transplant, though lung transplant recipients (LTR) carry the highest risk of CMV infection, and CMV-associated comorbidities compared to recipients of other solid organ transplants. Despite potent antivirals, CMV remains a significant driver of chronic lung allograft dysfunction (CLAD), re-transplantation, and death.

View Article and Find Full Text PDF
Article Synopsis
  • Acute lung allograft dysfunction (ALAD) is a warning sign for chronic lung allograft dysfunction (CLAD), prompting the need for biomarkers to assess the risk of progression.
  • Researchers conducted a study using single cell RNA sequencing on bronchoalveolar lavage (BAL) samples from lung transplant recipients to differentiate immune cell responses in patients with ALAD compared to those with stable function.
  • Results indicated significant differences in immune cell populations, with a specific macrophage cluster and CD8 T cells associated with ALAD progression; discordance between these cells was linked to a higher risk of severe graft dysfunction or death, underscoring the potential protective role of anti-inflammatory macrophages.
View Article and Find Full Text PDF
Article Synopsis
  • * Two groups were compared: one with laboratory tests on postoperative days 1 and 3 (LAB group) and one without these tests (control group).
  • * Results indicated no significant advantages for the LAB group in terms of complication rates, and routine monitoring led to longer hospital stays, suggesting limited benefits of this approach.
View Article and Find Full Text PDF

Acute lung injury (ALI) carries a high risk of mortality but has no established pharmacologic therapy. We previously found that experimental ALI occurs through natural killer (NK) cell NKG2D receptor activation and that the cognate human ligand, MICB, was associated with ALI after transplantation. To investigate the association of a common missense variant, , with ALI.

View Article and Find Full Text PDF

Many lung transplant recipients fail to derive the expected improvements in functioning, HRQL, or long-term survival. Sleep may represent an important, albeit rarely examined, factor influencing lung transplant outcomes. Within a larger cohort study, 141 lung transplant recipients completed the Medical Outcomes Study (MOS) Sleep Scale along with a broader survey of patient-reported outcome (PRO) measures and frailty assessment.

View Article and Find Full Text PDF

Primary graft dysfunction (PGD) limits clinical benefit after lung transplantation, a life-prolonging therapy for patients with end-stage disease. PGD is the clinical syndrome resulting from pulmonary ischemia-reperfusion injury (IRI), driven by innate immune inflammation. We recently demonstrated a key role for NK cells in the airways of mouse models and human tissue samples of IRI.

View Article and Find Full Text PDF

Primary graft dysfunction (PGD) is a major risk factor for chronic lung allograft dysfunction (CLAD) following lung transplantation, but the mechanisms linking these pathologies are poorly understood. We hypothesized that the replicative stress induced by PGD would lead to erosion of telomeres, and that this telomere dysfunction could potentiate CLAD. In a longitudinal cohort of 72 lung transplant recipients with >6 years median follow-up time, we assessed tissue telomere length, PGD grade, and freedom from CLAD.

View Article and Find Full Text PDF

Background: The main concerns following sleeve gastrectomy (SG) include the risk of gastroesophageal reflux disease (GERD) and its complications, such as Barrett's esophagus (BE). However, there is conflicting data on esophageal conditions, and studies on alterations of gastric mucosa after SG are lacking, despite reported cases of gastric cancer. Our aim was to assess esophageal and gastric lesions after SG.

View Article and Find Full Text PDF

Unlabelled: Large-airway lymphocytic inflammation (LB), assessed on endobronchial biopsies, has been associated with acute cellular rejection and chronic lung allograft dysfunction (CLAD). Azithromycin (AZI) prophylaxis has been used to prevent airway inflammation and subsequent CLAD, with inconsistent results. We hypothesized that AZI prophylaxis would be associated with reduced LB, changes in bronchoalveolar lavage (BAL) immune cell populations, and improved CLAD-free survival.

View Article and Find Full Text PDF

Ductal carcinoma in-situ (DCIS) accounts for 20-25% of all new breast cancer diagnoses. DCIS has an uncertain risk of progression to invasive breast cancer and a lack of predictive biomarkers may result in relatively high levels (~ 75%) of overtreatment. To identify unique prognostic biomarkers of invasive progression, crystallographic and chemical features of DCIS microcalcifications have been explored.

View Article and Find Full Text PDF

Background: After lung transplantation, both frailty and chronic lung allograft dysfunction (CLAD) commonly develop, and when they do, are associated with poorer outcomes. Given their potential shared mechanisms, we sought to explore the temporal relationship between frailty and CLAD onset.

Methods: In a single center, we prospectively measured frailty by the short physical performance battery (SPPB) repeatedly after transplant.

View Article and Find Full Text PDF

Neuroblastoma RAS (NRAS) is an oncogene that is deregulated and highly mutated in cancers including melanomas and acute myeloid leukemias. The 5' untranslated region (UTR) (5' UTR) of the NRAS mRNA contains a G-quadruplex (G4) that regulates translation. Here we report a novel class of small molecule that binds to the G4 structure located in the 5' UTR of the NRAS mRNA.

View Article and Find Full Text PDF
Article Synopsis
  • The Italian CMT Registry collects data on Charcot-Marie-Tooth (CMT) disease, with 1012 patients registered and a focus on a minimal dataset and encrypted data.
  • Among the patients, demyelinating CMT is the most prevalent subtype, with PMP22 duplications being the most common genetic mutation found.
  • The registry highlights the various clinical features and progression of different CMT types, showing the utility of the database for future clinical research and trials.
View Article and Find Full Text PDF